Presentation is loading. Please wait.

Presentation is loading. Please wait.

Approach to Abnormal Uterine Bleeding

Similar presentations


Presentation on theme: "Approach to Abnormal Uterine Bleeding"— Presentation transcript:

1 Approach to Abnormal Uterine Bleeding
Brent E. Seibel, MD Chief, Benign Gynecology Medical Director, UF Health North Jacksonville Associate Professor of Obstetrics and Gynecology University of Florida College of Medicine-Jacksonville

2 Disclosures I have no conflicts to disclose

3 Objectives Describe nomenclature, work up and management of abnormal uterine bleeding Illustrate treatment plan options for the PCP

4 Resources Committee on Practice Bulletins-Gynecology. Practice Bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol 2012; 120:197 Munro MG, Critchley HO, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011; 113:3 UpToDateR : Approach to abnormal uterine bleeding in nonpregnant reproductive-age women.

5 Introduction Abnormal uterine bleeding (AUB)
Menstrual bleeding of abnormal quantity, duration, or schedule AUB terminology more descriptive than menorrhagia, metrorrhagia, etc. Accounts for 1/3 outpatient visits to gynecologists Wide variety of local and systemic diseases or medications Annual prevalence of 53 per 1000 women Common etiologies Structural, anovulation, disorders of hemostasis or neoplasia

6 Abnormal Uterine Bleeding
Heavy Menstrual Bleeding (AUB-HMB) Intermenstrual Menstrual Bleeding (AUB-IMB) PALM: Structural Polyp (AUB-P) Adenomyosis (AUB-A) Leiomyoma (AUB-L) Malignancy and Hyperplasia (AUB-M) COEIN: Non-Structural Coagulopathy (AUB-C) Ovulatory Dysfunction (AUB-O) Endometrial (AUB-E) Iatrogenic (AUB-I) Not Yet Classfied (AUB-N)

7 PALM: Structural Polyps

8 PALM: Structural Adenomyosis

9 PALM: Structural Leiomomas

10 PALM: Structural Malignancy and Hyperplasia

11 COEIN: Non-structural
Coagulopathy Inherited and acquired May occur in up to 20% of patients with HMB Indications for evaluation HMB since menarche Postpartum hemorrhage, excessive surgical bleeding or bleeding with dental work, or any two of the following Bruising 1-2 times per month Epitaxis 1-2 times per month Frequent gum bleeding Family history of bleeding symptoms

12 COEIN: Non-structural
Ovulatory Dysfunction (From amenorrhea and oligomenorrhea to frequent irregular menses) Hypothalimic hypogonadotropic hypogonadism Thyroid dysfunction Hyperprolactinemia Hyperandrogenemia/PCOS Premature ovarian insufficiency Idiopathic anovulation Chronic illness

13 COEIN: Non-structural
Endometrial Abnormalities Abnormal endometrial angiogenesis Prostaglandin production Vasoconstriction Increased fibrinolysis

14 COEIN: Non-structural
Iatrogenic Contraceptives OCPs, patch or ring Depo Provera (DMPA) Contraceptive implant (Nexplanon) Intrauterine device (IUD) Other medications Antipsychotics Anticoagulants other

15 Evaluation: History Age of menarche Menstrual bleeding pattern
Severity of bleeding Pain Medical history Surgical history Family history Bleeding disorders, PCOS, diabetes, cancer

16 Evaluation: Medications
Anticoagulants Hormonal medications NSAIDS Antipsychotics Supplements

17 Evaluation: Physical Exam
Weight extremes Skin Acanthosis nigrans Hirsuitism Acne Pallor Petechiae or echymosis Thyroid Abdomen Pelvic

18 Evaluation: Labs Pregnancy test STD testing if indicated Pap smear CBC
TSH

19 Evaluation: Labs Bleeding disorder Hyperandrogenism/PCOS PT/PTT/INR
Platelet function Fibrinogen Hyperandrogenism/PCOS Testosterone DHEAS 17-OHP HgbA1C, lipids, CMP

20 Evaluation: Labs Amenorrhea/Oligomenorrhea Prolactin FSH/LH Estradiol

21 Evaluation: Imaging Transvaginal ultrasound
Saline Infusion Sonohysterogram (SIS) Excellent for cavity assessment MRI Fibroid mapping Mullerian anomalies Adenomyosis

22 Evaluation: Tissue Sampling
Endometrial biopsy Women > age 45 with AUB Women < age 45 with chronic anovulation Obese PCOS Unopposed estrogens Hysteroscopy D&C

23 Treatment: Medical Combined oral contraceptives Progesterone therapy
Intramuscular Levonorgestrel intrauterine system (IUD) Tranexamic acid NSAIDs

24 Treatment: Surgical Dilation and Curettage (D&C) Hysteroscopy
Diagnostic Operative (polypectomy, myomectomy) Endometrial ablation Uterine artery embolization (UAE) Myomectomy Hysterectomy

25 Adolescent with AUB (HMB or IMB)
History and physical exam *Pelvic ultrasound Peripubertal anovulatory bleeding Bleeding disorder Expectant management Treatment with OCPs or cyclic MPA Refer Ped/Ad Gyn or Hematology

26 Reproductive Age with AUB-HMB
History, Physical exam and labs *Pelvic ultrasound Abnormal pelvic exam Normal pelvic exam Success! No further workup Pelvic ultrasound Treat abnormality Treat: OCPs Progesterone LngIUD Tranexamic acid NSAIDs Pelvic ultrasound Refer to GYN

27 Reproductive Age with AUB-IMB
History, Physical exam and labs *Pelvic ultrasound Short-term IMB Long-standing IMB Expectant management or Treatment: OCPs Progesterone Pelvic ultrasound (TVS) Cavity evaluation* GYN referral EmBx* Treatment failure TVS/Cavity evaluation GYN referral Success! No further workup

28 Summary AUB a common condition among reproductive age women
Evaluation and initial management by PCP Differentiate between structural and non- structural causes PALM – COEIN terminology

29 Thank you! Questions?


Download ppt "Approach to Abnormal Uterine Bleeding"

Similar presentations


Ads by Google